United States Respiratory Measurement Devices Market Outlook to 2025

GlobalData
82 Pages - GLDATA66251
$4,995.00

Summary

GlobalData’s new report, United States Respiratory Measurement Devices Market Outlook to 2025, provides key market data on the United States Respiratory Measurement Devices market. The report provides value, in millions of US dollars, volume (in units) and average prices (USD) within market segments - Pulse Oximeter Systems, Capnographs, Spirometers and Peak Flow Meters.

The report also provides company shares and distribution shares data for each of these market segments, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular market and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

- Market size and company share data for Respiratory Measurement Devices market segments - Pulse Oximeter Systems, Capnographs, Spirometers and Peak Flow Meters.
- Annualized market revenues (USD million) and volume (units) data for each of the market segments. Data is provided from 2015 to 2025.
- 2017 company share and distribution share data for Respiratory Measurement Devices market.
- Global corporate-level profiles of key companies operating within the United States Respiratory Measurement Devices market.
- Key players covered include Medtronic plc, Masimo Corp, Nonin Medical Inc and others.

Reasons to buy

- Develop business strategies by identifying the key market categories poised for strong growth in the future.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the market.
- Develop investment strategies by identifying the key market categories expected to register strong growth in the near future.
- What are the key distribution channels and what’s the most preferred mode of product distribution - Identify, understand and capitalize.



Companies Mentioned
Medtronic Plc
Masimo Corp
Nonin Medical Inc
Medical International Research Srl
Vyaire Medical Inc
Philips Respironics Inc

'

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 4
1.2 List of Figures 4
2 Introduction 5
2.1 What Is This Report About? 5
2.2 Respiratory Measurement Devices Market Segmentation 5
2.3 Definitions of Markets Covered in the Report 6
3 Respiratory Measurement Devices Market, United States 8
3.1 Respiratory Measurement Devices Market, United States, Revenue ($m), 2015-2025 8
3.1.1 Capnographs Market, United States, Revenue ($m), by Segment, 2015-2025 11
3.1.2 Pulse Oximeter Systems Market, United States, Revenue ($m), by Segment, 2015-2025 13
3.1.3 Spirometers Market, United States, Revenue ($m), by Segment, 2015-2025 16
3.2 Respiratory Measurement Devices Market, United States, Volume (Units), 2015-2025 18
3.2.1 Capnographs Market, United States, Volume (Units), by Segment, 2015-2025 21
3.2.2 Pulse Oximeter Systems Market, United States, Volume (Units), by Segment, 2015-2025 23
3.2.3 Spirometers Market, United States, Volume (Units), by Segment, 2015-2025 26
3.3 Respiratory Measurement Devices Market, United States, Average Price ($) , 2015-2025 28
3.4 Respiratory Measurement Devices Market, United States, Distribution Share by Revenue ($m), 2017 30
3.5 Respiratory Measurement Devices Market, United States, Company Share by Revenue ($m), 2017 31
4 Overview of Key Companies in United States, Respiratory Measurement Devices Market 33
4.1 Medtronic Plc 33
4.1.1 Company Overview 33
4.2 Masimo Corp 33
4.2.1 Company Overview 33
4.3 Nonin Medical Inc 33
4.3.1 Company Overview 33
4.4 Medical International Research Srl 34
4.4.1 Company Overview 34
4.5 Vyaire Medical Inc 34
4.5.1 Company Overview 34
4.6 Philips Respironics Inc 34
4.6.1 Company Overview 34
5 Respiratory Measurement Devices Market Pipeline Products 35
6 Financial Deals Landscape 37
6.1 Debt Offerings 37
6.1.1 Edwards Lifesciences Prices Public Offering of 4.3% Notes Due 2028 for USD600 Million 37
6.2 Equity Offerings 39
6.2.1 Edwards Lifesciences Plans to Raise up to USD34.5 Million in Public Offering of Shares 39
6.2.2 Soleno Therapeutics Files Registration Statement for Public Offering of Shares 40
6.2.3 Soleno Therapeutics to Raise USD15 Million in Private Placement of Shares and Warrants 41
6.3 Partnerships 43
6.3.1 Soleno Therapeutics and Capnia Form Joint Venture with OptAsia Healthcare 43
7 Recent Developments 44
7.1 Corporate Communications 44
7.1.1 Jul 11, 2018: Natus Medical Announces Leadership Changes 44
7.1.2 May 09, 2018: AMETEK names Matthew Conti as vice president, human resources 45
7.1.3 May 09, 2018: AMETEK hires David Samyn as vice president and general manager for materials analysis division 45
7.1.4 Apr 02, 2018: ResMed Hires Bobby Ghoshal as First Chief Technology Officer 45
7.1.5 Feb 20, 2018: Mark Scheuer Elected Vice President, Environmental, Health & Safety 46
7.1.6 Jan 05, 2018: Natus Appoints Leslie McDonnell as Vice President and General Manager of its Newborn Care Business Unit 46
7.1.7 Nov 17, 2017: ResMed Elects Karen Drexler to Its Board of Directors 46
7.2 Financial Announcements 47
7.2.1 May 16, 2018: Soleno Therapeutics Provides Corporate Update and Reports First Quarter 2018 Financial Results 47
7.2.2 May 11, 2018: Novartis Announces FDA Approval of Gilenya as the First Disease-modifying Therapy for Pediatric Relapsing Multiple Sclerosis 48
7.2.3 May 10, 2018: CASMED Reports First-Quarter 2018 Financial Results 50
7.2.4 May 02, 2018: Masimo Reports First Quarter 2018 Financial Results 51
7.2.5 May 02, 2018: AMETEK Announces Record First Quarter Results And Raises 2018 Guidance 51
7.2.6 Apr 26, 2018: ResMed Announces Results for the Third Quarter of Fiscal Year 2018 52
7.2.7 Apr 25, 2018: Natus Medical Announces First Quarter Financial Results 54
7.2.8 Apr 24, 2018: Edwards Lifesciences Announces First Quarter 2018 Financial Results 54
7.2.9 Apr 02, 2018: Soleno Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full-Year 2017 Financial Results 56
7.2.10 Mar 14, 2018: CASMED Announces 2017 Fourth-Quarter and Full-Year Financial Results 57
7.2.11 Feb 27, 2018: The European Medicines Agency Grants Accelerated Assessment for Shire's Lanadelumab Being Evaluated for the Prevention of Attacks in Hereditary Angioedema Patients Aged 12 Years and Older 58
7.2.12 Feb 27, 2018: Masimo Reports Fourth Quarter 2017 Financial Results 59
7.2.13 Feb 07, 2018: Natus Medical Announces Fourth Quarter and Full Year 2017 Financial Results 60
7.2.14 Feb 01, 2018: AMETEK Announces Record Fourth Quarter and Full Year Results and Issues 2018 Guidance 62
7.2.15 Feb 01, 2018: Edwards Lifesciences Reports Fourth Quarter Results 63
7.2.16 Jan 22, 2018: ResMed Reports Second Quarter of Fiscal Year 2018 Financial Results 64
7.2.17 Jan 08, 2018: Natus Medical Announces 2018 Annual and First Quarter Financial Guidance 65
7.2.18 Dec 07, 2017: Edwards Lifesciences Outlines Growth Strategy At Annual Investor Conference 66
7.2.19 Nov 09, 2017: VBL Therapeutics to Present at the 22nd Annual Scientific Meeting of the Society for Neuro-Oncology (SNO) on November 18 67
7.2.20 Nov 09, 2017: CASMED Reports Third-Quarter 2017 Financial Results 68
7.2.21 Oct 31, 2017: Masimo Reports Third Quarter 2017 Financial Results 69
7.2.22 Oct 26, 2017: ResMed Announces Results for the First Quarter of Fiscal Year 2018 70
7.2.23 Oct 25, 2017: Natus Medical Announces Third Quarter 2017 Financial Results 71
7.2.24 Oct 24, 2017: Edwards Lifesciences Announces Third Quarter Results 72
7.3 Legal And Regulatory 74
7.3.1 Oct 06, 2017: ResMed's European Patents Infringed by Fisher & Paykel in Germany 74
7.4 Other Significant Developments 74
7.4.1 Jun 26, 2018: InfuSystem Holdings Selected as an Official Distributor of CADD Infusion Therapy Products by Smiths Medical 74
7.5 Product News 74
7.5.1 Nov 27, 2017: Masimo Announces FDA Clearance and Worldwide Release of NomoLine Capnography Sampling Lines 74
8 Appendix 76
8.1 Research Methodology 77
8.1.1 Coverage 77
8.1.2 Secondary Research 77
8.1.3 Primary Research 78
8.1.4 Market Modeling and Forecasting 79
8.1.5 Company Share Analysis 80
8.1.6 Distribution Share Analysis 81
8.1.7 Benchmarking 81
8.2 GlobalData Consulting 81
8.3 Contact Us 82
8.4 Disclaimer 82

1.1 List of Tables
Table 1: Respiratory Measurement Devices Market, United States, Revenue ($m), USD Constant, 2015-2020 9
Table 2: Respiratory Measurement Devices Market, United States, Revenue ($m), USD Constant, 2021-2025 10
Table 3: Capnographs Market, United States, Revenue ($m), USD Constant, 2015-2020 12
Table 4: Capnographs Market, United States, Revenue ($m), USD Constant, 2021-2025 12
Table 5: Pulse Oximeter Systems Market, United States, Revenue ($m), USD Constant, 2015-2020 14
Table 6: Pulse Oximeter Systems Market, United States, Revenue ($m), USD Constant, 2021-2025 15
Table 7: Spirometers Market, United States, Revenue ($m), USD Constant, 2015-2020 17
Table 8: Spirometers Market, United States, Revenue ($m), USD Constant, 2021-2025 17
Table 9: Respiratory Measurement Devices Market, United States, Volume (Units), 2015-2020 19
Table 10: Respiratory Measurement Devices Market, United States, Volume (Units), 2021-2025 20
Table 11: Capnographs Market, United States, Volume (Units), 2015-2020 22
Table 12: Capnographs Market, United States, Volume (Units), 2021-2025 22
Table 13: Pulse Oximeter Systems Market, United States, Volume (Units), 2015-2020 24
Table 14: Pulse Oximeter Systems Market, United States, Volume (Units), 2021-2025 25
Table 15: Spirometers Market, United States, Volume (Units), 2015-2020 27
Table 16: Spirometers Market, United States, Volume (Units), 2021-2025 27
Table 17: Respiratory Measurement Devices Market, United States, Average Price ($), 2015-2020 28
Table 18: Respiratory Measurement Devices Market, United States, Average Price ($), 2021-2025 29
Table 19: Respiratory Measurement Devices Market, United States, Distribution Share by Revenue ($m), USD Constant, 2017 30
Table 20: Respiratory Measurement Devices Market, United States, Company Share by Revenue ($m), USD Constant, 2017 32
Table 21: Respiratory Measurement Devices Market Pipeline Products 35
Table 22: Edwards Lifesciences Prices Public Offering of 4.3% Notes Due 2028 for USD600 Million 37
Table 23: Edwards Lifesciences Plans to Raise up to USD34.5 Million in Public Offering of Shares 39
Table 24: Soleno Therapeutics Files Registration Statement for Public Offering of Shares 40
Table 25: Soleno Therapeutics to Raise USD15 Million in Private Placement of Shares and Warrants 41
Table 26: Soleno Therapeutics and Capnia Form Joint Venture with OptAsia Healthcare 43
Table 27: Total Number of Primary Research Participants, Anesthesia and Respiratory Devices Market, by Country 79

1.2 List of Figures
Figure 1: Respiratory Measurement Devices Market, United States, Revenue ($m), USD Constant, 2015-2025 8
Figure 2: Capnographs Market, United States, Revenue ($m), USD Constant, 2015-2025 11
Figure 3: Pulse Oximeter Systems Market, United States, Revenue ($m), USD Constant, 2015-2025 13
Figure 4: Spirometers Market, United States, Revenue ($m), USD Constant, 2015-2025 16
Figure 5: Respiratory Measurement Devices Market, United States, Volume (Units), 2015-2025 18
Figure 6: Capnographs Market, United States, Volume (Units), 2015-2025 21
Figure 7: Pulse Oximeter Systems Market, United States, Volume (Units), 2015-2025 23
Figure 8: Spirometers Market, United States, Volume (Units), 2015-2025 26
Figure 9: Respiratory Measurement Devices Market, United States, Company Share (%) 2017 31

$4,995.00

Research Assistance

We can help you find
data and analyses
relevant to your needs,
or prepare a custom report.

Please contact us at [email protected]
or +1 212 564 2838

 

Custom Research

Contact us to speak
with your industry analyst.

[email protected] 
+1 212 564 2838

 



Discount Codes

Request Discount Codes
for reports of interest to you.

[email protected]
+1 212 564 2838



Browse All Reports